A detailed history of Cross Staff Investments Inc transactions in Amgen Inc stock. As of the latest transaction made, Cross Staff Investments Inc holds 626 shares of AMGN stock, worth $164,418. This represents 0.16% of its overall portfolio holdings.

Number of Shares
626
Holding current value
$164,418
% of portfolio
0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $193,671 - $211,199
626 New
626 $201,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cross Staff Investments Inc Portfolio

Follow Cross Staff Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cross Staff Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cross Staff Investments Inc with notifications on news.